Media 2018-03-28T01:52:01+00:00

IN THE NEWS

Applied AI – January, 2018

14 Healthcare AI Applications

Pulmonary Fibrosis News – January, 2018

NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach

Medical Device and Diagnostic Industry (MD+DI) – January, 2018

Sifting Nuggets of Truth out of the AI Hooplah

MedCity News – January, 2018

Andy Slavitt: When it comes to AI, it is the best of times, worst of times story

WuXi AppTec – October, 2017

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines

PharmTech – September, 2017

Expediting the Discovery and Development of Drugs – Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches

The Scientist – January, 2017

Repurposing Existing Drugs for New Indications

SOCIAL MEDIA

Follow us on Twitter

2 months ago
Our CEO @biotechfounder highlights our collaboration with @3LakesPartners as "a model going forward for a lot of biotechs". Profiled in the @WSJ: https://t.co/wKZWGRNwcK
4 months ago
Our CTO, Asim Siddiqui's talk on #PrecisionMedicine at #PMWC18 is standing room only! #ArtificialIntelligence is THE trend for 2018 https://t.co/OrliXTHT4Q
NuMedii photo
Gini Deshpande @biotechfounder
Proud of @NuMedii CTO Asim Siddiqui giving an amazing talk on our work on #AI and #PrecisionMedicine #PMWC18. Room is packed! https://t.co/aNgsPIDrRE
4 months ago
Wondering what NuMedii has been working on lately? Our CTO Asim Siddiqui will be highlighting our work on #PrecisionMedicine #drugdiscovery using #ArtificialIntelligence and #BigData at #PMWC18 #AI & #DataScience showcase on Jan 22 at 2.30 pm
https://t.co/uZIY5KoZuH

Join us on Facebook.

NuMedii
NuMedii4 months ago

Our CEO will be joining other AI experts on Tuesday's lunch panel at #JPM18 is focused on AI. Speakers incl @JamieHeywood @patientslikeme, @ASlavitt, @biotechfounder @NuMedii, @DrShlain @healthloop

NuMedii
NuMedii4 months ago

Warm welcome to our IPF Advisors: Naftali Kaminski, Gisli Jenkins, Toby Maher, David Schwartz, Zea Borok, Paul Wolters and Kevin Brown. Grateful to have your input & help as we develop new therapies for IPF. Thanks Three Lakes Partners for helping us connect!

NuMedii
NuMedii10 months ago

Congratulations @NuMedii co-founder & SAB member @atulbutte, new Chan-Zuckerberg Distinguished Prof! Well deserved!!
https://www.ucsf.edu/news/2017/07/407921/mark-zuckerberg-priscilla-chan-donate-10m-advance-health-using-big-data

PRESS RELEASES

January 5, 2018

World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board

April 11, 2017

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

View more…